Low-Dose Acyclovir Prophylaxis for Varicella zoster Reactivation in Autologous Hematopoietic Cell Transplantation Recipients

Varicella zoster virus (VZV) reactivation after autologous hematopoietic cell transplantation (auto-HCT) may be observed in a quarter of patients. Currently, prophylactic use of acyclovir 800 mg twice daily or valacyclovir 500 mg twice daily is recommended for prophylaxis against VZV reactivation fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Fei, Naomi, Shah, Nilay, Cumpston, Aaron, Wen, Sijin, Ross, Kelly G., Craig, Michael, Kanate, Abraham S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Atlantis Press 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432389/
https://www.ncbi.nlm.nih.gov/pubmed/34595417
http://dx.doi.org/10.2991/chi.d.190329.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432389/
https://www.ncbi.nlm.nih.gov/pubmed/34595417
http://dx.doi.org/10.2991/chi.d.190329.001

Ejemplares similares